The Efficacy of Denosumab to Reduce Osteoporosis After Spinal Cord Injury
Phase of Trial: Phase IV
Latest Information Update: 13 Mar 2018
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 12 Mar 2018 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 12 Mar 2018 Planned primary completion date changed from 1 May 2017 to 1 May 2019.
- 25 Mar 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.